Skip to content
Medical Health Aged Care

KFSHRC Empowers Future Healthcare Leaders with Innovative Research Programs

King Faisal Specialist Hospital & Research Centre 2 mins read

3

RIYADH, Saudi Arabia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) solidifies its medical education and research leadership through its Academic & Training Affairs (ATA) Department, which offers structured learning, intensive workshops, and personalized mentorship.

A highlight of KFSHRC’s medical education is the King Faisal Aspiring Research Program, developed in partnership with the Research and Innovation Centre and Al-Faisal University. This program equips trainees with advanced clinical research skills through a flexible 12-month to 18-month curriculum. Designed to guide participants through the entire research process, this initiative has already seen significant success, with over 60 research proposals submitted, signifying its effectiveness in fostering skilled researchers.

Similarly, the Genomic Track Program, planned to be launched in September 2024, will offer specialized training in precision medicine. This three-month program will provide in-depth education across five key modules, targeting residents and fellows passionate about genomics. With a class size limited to 10 trainees per course, the program ensures focused training, preparing participants to lead in the rapidly evolving field of genomic medicine.

KFSHRC’s initiatives align with global trends in precision medicine, which is projected to reach a market value of $144 billion by 2028. This growth is driven by genomics and personalized healthcare advances, enabling more targeted and effective treatments. KFSHRC’s precision medicine and clinical research efforts are positioning Saudi Arabia as a regional leader and contributing significantly to global advancements through pioneering genomic studies and innovative clinical trials.

By advancing education and research in these critical areas, KFSHRC is preparing the next generation of healthcare professionals and reinforcing its role as a global leader in medicine within Saudi Arabia and internationally.

It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and North Africa and 20th globally in the list of the world’s top 250 Academic Medical Centers for the second consecutive year and recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals.

mediacoverage@kfshrc.edu.sa

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c1e1a469-af47-4897-8112-40e535ba838b


Primary Logo

More from this category

  • Biotechnology, Medical Health Aged Care
  • 09/12/2024
  • 15:45
Jane Morgan Management

NEXSEN Biotech Announces Pre-IPO Fundraising to Revolutionise Point-of-Care Diagnostics

Sydney, Australia – 9December, 2024 |NEXSEN Biotech Pty Ltd (“NEXSEN”), a pioneering diagnostics company, is excited to announce the launch of its pre-IPO fundraising round, targeting $2 million to $3 million. With a mission to improve global health outcomes, NEXSEN is set to deliver cutting-edge point-of-care diagnostic solutions that address critical unmet medical needs. At the heart of NEXSEN's innovation is StrepSure®, the world's first rapid diagnostic test for Group B Streptococcus (“GBS”). This revolutionary technology leverages advanced nanoparticle engineering and aptamer discovery, ensuring quick, accurate, and cost-effective diagnosis at the point of care. StrepSure® is poised to make life-saving…

  • Government Federal, Medical Health Aged Care
  • 09/12/2024
  • 12:14
Catholic Health Australia

CHA backs AMA push for greater access to out-of-hospital care

Catholic Health Australia supports the Australian Medical Association’s call for greater access to out-of-hospital care for patients, outlined in its position paper released today. “We have been calling for reform to out-of-hospital care for the past year and are pleased to see the sector unite around this issue,” said Catholic Health Australia CEO Jason Kara. “Treatments like chemotherapy, dialysis, wound care, palliative care and post-surgical rehab can be conducted safely at home with better outcomes - but millions of patients are missing out. “We urgently need reforms that allow patients and their doctors to choose where they receive their care,…

  • Medical Health Aged Care
  • 09/12/2024
  • 10:55
Monash University

Monash Expert: Australia’s growing arthritis burden

The number of people living with arthritis in Australia is projected to increase by a third by 2040, suggests a modelling study, published in The Lancet Rheumatology. The model projects about 5.4 million Australians will have arthritis in 2040, 1.3 million (31 per cent) more than the estimated number of cases for 2025. Annual health system spending on osteoarthritis – the most common type of arthritis, and rheumatoid arthritis, the most common type of inflammatory arthritis – is forecast to exceed AUD $11.9 billion by 2040, if current spending levels continue, estimated at AUD $2,100 per person with osteoarthritis and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.